EVALUATION OF DOSE-RESPONSE, PHARMACODYNAMIC AND PHARMACOKINETIC BIOEQUIVALENCE OF FILGRASTIM IN HEALTHY MALE VOLUNTEERS AFTER SINGLE AND MULTIPLE-DOSE SUBCUTANEOUS ADMINISTRATION OF THE TEST INJECTABLE FORMULATION BK0023 VS. NEUPOGEN®: